Edition:
United States

AveXis Inc (AVXS.OQ)

AVXS.OQ on NASDAQ Stock Exchange Global Select Market

100.05USD
2:25pm EST
Change (% chg)

$1.11 (+1.12%)
Prev Close
$98.94
Open
$99.21
Day's High
$102.15
Day's Low
$98.86
Volume
124,605
Avg. Vol
153,190
52-wk High
$108.27
52-wk Low
$45.37

Select another date:

Wed, Dec 13 2017

BRIEF-Avexis plans to initiate Phase 1 trial in SMA Type 2

* AVEXIS ANNOUNCES PLAN TO INITIATE PHASE 1 TRIAL IN SMA TYPE 2 UTILIZING INTRATHECAL DELIVERY OF AVXS-101 Source text for Eikon: Further company coverage:

BRIEF-Avexis posts Q3 loss per share $1.52

* Avexis reports third quarter 2017 financial and operating results

BRIEF-Avexis Inc CFO Thomas Dee resigns

* Avexis Inc - ‍on October 14 Thomas J. Dee resigned as senior vice president, chief financial officer - SEC filing

BRIEF-AveXis to report top-line data from phase 1 clinical trial of AVXS-101

* AveXis to report top-line data from the Phase 1 clinical trial of AVXS-101 in SMA Type 1 at the International Annual Congress Of The World Muscle Society

BRIEF-Avexis to initiate pivotal trial of AVXS-101 in SMA type 1

* Avexis announces plan to initiate pivotal trial of AVXS-101 in SMA type 1 using product from new GMP commercial process

BRIEF-AveXis reports Q2 loss per share $2.07

* AveXis reports second quarter 2017 financial and operating results

Select another date: